July 13, 2023
Insys Therapeutics Inc. founder John Kapoor's release to home confinement less than halfway through a 5½-year prison term and the expectation that Theranos founder Elizabeth Holmes will significantly reduce her 11-year sentence are emblematic of a decarceration movement that has disproportionately helped white collar offenders, experts told Law360.
June 26, 2023
Insys Therapeutics Inc. founder John Kapoor is out of prison after serving about two years of a 66-month term, his lawyers said Monday, bringing a close to a signature health care fraud prosecution in which Kapoor and others were convicted of bribing doctors to prescribe powerful opioids.
April 25, 2023
Insys Therapeutics Inc. founder John Kapoor said Tuesday that the Massachusetts U.S. attorney convinced the Bureau of Prisons that he should remain in prison for an opioid kickback scheme through a "misleading diatribe" that also led his warden to change his mind about his early release request.
April 12, 2023
A Massachusetts federal judge on Wednesday sought more information about why Insys Therapeutics Inc. founder John Kapoor was deemed ineligible for early release from his prison term, bristling at a document that suggested the octogenarian is a threat to public safety.
February 28, 2023
Insys Therapeutics Inc. founder John Kapoor said Monday that prosecutors are wrong to argue that he should remain in prison despite suffering multiple heart attacks, claiming that an early release into home confinement may allow for "life-saving" care.
February 24, 2023
Now that the U.S. Supreme Court has said it will not hear Insys Therapeutics founder John Kapoor's appeal of his racketeering conspiracy conviction, federal prosecutors have told a Massachusetts federal judge that they want all of the $24.5 million of his that the U.S. Marshals have been holding onto.
February 21, 2023
Federal prosecutors said Insys Therapeutics Inc. founder John Kapoor should stay in prison for his role in the opioid maker's kickback scheme, countering his argument that two heart attacks and the ongoing pandemic pose a serious enough threat to his health to set him free.
February 01, 2023
The convicted founder of Insys Therapeutics Inc. asked a Massachusetts federal judge to leave prison before the end of his 5½-year term for orchestrating an opioid kickback scheme, saying in a late Tuesday motion that he's had two heart attacks behind bars and needs care that the prison system cannot provide.
August 29, 2022
A Massachusetts federal judge said Monday that cutting short the prison sentence of a former Insys Therapeutics executive convicted for an opioid kickback scheme would "send the wrong message."
August 04, 2022
Federal prosecutors are asking a Massachusetts federal court not to grant a compassionate release to a former Insys executive convicted of leading an opioid kickback scheme, saying he spent his time at the company "making the bed he now finds himself in" and has not shown compelling circumstances to cut his incarceration short.